DoW Tuberous Sclerosis Complex, Idea Development Award
About
Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Idea Development Award (IDA) supports conceptually innovative and high-impact research that could ultimately lead to critical discoveries in tuberous sclerosis complex (TSC) research and/or improvements in patient care. Distinctive Features: This funding mechanism allows for established and new-to-the-field investigators. New-to-the-field investigators are independent investigators that are early in their faculty appointments and/or established investigators transitioned from other research fields into TSC research. Applications to the New-to-the-Field option will compete separately from the Established Investigators submitting to the regular Idea Development Award (IDA).
The DoW Tuberous Sclerosis Complex Idea Development Award (IDA) is a research funding opportunity designed for investigators seeking to advance understanding of tuberous sclerosis complex (TSC) through innovative, high-impact research. This grant supports conceptually innovative projects that could lead to critical discoveries in TSC research and meaningful improvements in patient care. The program is uniquely structured to welcome both established investigators with a track record in TSC research and new-to-the-field investigators—including early-career faculty and established researchers transitioning into TSC research from other disciplines. Applicants are encouraged to pursue bold, creative approaches that address gaps in TSC knowledge and treatment. This funding mechanism recognizes that breakthrough discoveries often come from fresh perspectives and novel methodologies. Researchers interested in contributing to TSC research should consider this opportunity to develop and test innovative ideas that could reshape the field and ultimately benefit patients living with tuberous sclerosis complex.
Funding Facts
● Applications openDeadline
August 6, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2026-08-06
Grant Type
federal
Application Cycle
Annual
Best For
Academic researchers, independent investigators, established and early-career scientists pursuing innovative tuberous sclerosis complex research
Frequently Asked Questions
Who is eligible for DoW Tuberous Sclerosis Complex, Idea Development Award?
The Idea Development Award supports both established and new-to-the-field investigators. New-to-the-field investigators include independent researchers early in their faculty appointments or established investigators transitioning into TSC research from other research fields. Applications from these groups compete separately from established investigators. For specific eligibility requirements regarding institutional affiliation, citizenship, and other criteria, consult the official program announcement or visit the funding agency's website.
How much funding does DoW Tuberous Sclerosis Complex, Idea Development Award provide?
Specific funding amounts for the FY26 cycle have not been publicly detailed. Award amounts typically vary based on research scope and project needs. Visit the official program website or contact the administering agency directly for current funding levels and budget guidelines.
How do I apply for DoW Tuberous Sclerosis Complex, Idea Development Award?
Applications are submitted through the standard federal grants process. The deadline for FY26 is August 6, 2026. Applicants should prepare a detailed research proposal outlining their innovative approach, expected impact, and timeline. Complete application instructions, required forms, and submission guidelines are available on the official program website. Applicants should review the full program announcement to understand all requirements and competitive review criteria.
What can DoW Tuberous Sclerosis Complex, Idea Development Award funding be used for?
Funding supports research aimed at advancing understanding of tuberous sclerosis complex and improving patient care. This includes conceptually innovative investigations that could lead to critical discoveries in TSC biology, pathology, clinical management, or therapeutic approaches. Research projects should address significant gaps in TSC knowledge. Consult the official program announcement for detailed information on allowable costs and budget categories.
Last updated: July 5, 2026